Key facts
| Price (PPV) | 6,742 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | pegfilgrastim |
| Class | Immunostimulants |
| ATC code | L03AA13 |
| Manufacturer | VIATRIS PHARMACEUTICALS |
| Presentation | Boite d'une seringue pré-remplie de 0.6 ML |
| Hospital price | 6,528 MAD |
| Data collected on | 9/8/2026 |
Indications
Réduction de la durée des neutropénies et de l’incidence des neutropénies fébriles chez les patients adultes traités par une chimiothérapie cytotoxique pour une pathologie maligne (à l’exception des leucémies myéloïdes chroniques et des syndromes myélodysplasiques).
Find an open pharmacy
On-call pharmacies near you
About Fulphila 6 mg / 0.6 ml
Fulphila 6 mg / 0.6 ml belongs to the immunostimulants therapeutic class. In Morocco, this drug is marketed by VIATRIS PHARMACEUTICALS and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Fulphila 6 mg / 0.6 ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Fulphila 6 mg / 0.6 ml
Answers to common questions from Moroccan patients about this drug.